SORA Technology has raised $2.5 million, closing the second tranche of its late seed round and bringing its total funding to $7.3 million. This investment, announced in late 2025 and widely reported in early 2026, will support the company’s efforts to enhance AI-driven disease prediction models and expand drone operations across multiple African countries combating malaria. The funding round attracted new investors, including Daiwa House Group Investment, Central Japan Innovative Research Fund I, and UNERI Capital Fund Series I, alongside existing shareholders, signaling growing confidence in SORA Technology’s innovative approach.
The Japan-based company uses a combination of drones, satellite imagery, and artificial intelligence to forecast and mitigate infectious diseases, with a primary focus on malaria in more than ten African nations, including Ghana, Sierra Leone, Benin, the Democratic Republic of the Congo, Senegal, Kenya, and Mozambique. By integrating these technologies, SORA Technology is able to identify mosquito breeding sites and predict high-risk areas, enabling health authorities to allocate resources more efficiently and target interventions such as larvicide application where they are most needed.
A major portion of the new capital will go toward improving SORA Technology’s AI models, increasing the precision of malaria outbreak predictions. Enhanced predictive capabilities are particularly significant in sub-Saharan Africa, where malaria remains a leading cause of mortality, responsible for approximately 610,000 deaths in 2024. Accurate forecasting can directly reduce transmission rates and save lives by supporting timely, targeted interventions.
The funding will also expand drone-based operations across partner countries. Drones provide rapid mapping of potential mosquito habitats, including in remote or difficult-to-access areas, delivering real-time data to inform ground-based control measures. This expansion builds on SORA Technology’s collaborations with international health organisations such as Unitaid and the World Health Organization, strengthening operational reach and effectiveness in malaria-endemic zones.
Beyond malaria, SORA Technology’s platform supports public health, environmental monitoring, and economic resilience. By optimising resource distribution, the technology helps protect vulnerable populations, particularly children under five, and alleviates the economic burden on affected communities. The company’s solutions also extend to sectors such as agriculture, mining, and infrastructure, showcasing versatile applications of its drone and AI technologies.
This funding positions SORA Technology for future growth and a forthcoming Series A round, while intensifying its on-the-ground efforts in Africa. By refining AI models, scaling drone operations, and enabling precise interventions, the company is poised to significantly reduce malaria incidence and mortality. The investment underscores the critical role of innovative technology and financing in addressing persistent public health challenges and promoting healthier communities across the continent.
